Dr. Reddy’s and Pharmazz, Inc. enter into licensing agreement to market first-in-class Centhaquine (Lyfaquin®)
Hyderabad, India; 27th March 2024 –Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to…